Association between inflammatory bowel disease and other autoimmune disorders

Prevalence of coexisting autoimmune disorders among inflammatory bowel disease (IBD) patients at a tertiary care centre in Riyadh, Saudi Arabia: a cross-sectional study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN78250941

Enrollment

400

Registered

2023-12-08

Start date

2023-09-13

Completion date

Unknown

Last updated

2024-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevalence of coexisting autoimmune disorders among IBD patients Digestive System

Interventions

The study will be conducted in Riyadh, the capital of Saudi Arabia, at a tertiary care center offering comprehensive care to many IBD patients, including diagnosis, treatment, and follow-up. Access to

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with either CD or UC based on internationally recognized criteria. 2. Age 14 years or above. 3. IBD is currently being treated at a specialized medical facility. 4. Availability of complete medical records for data extraction.

Exclusion criteria

Exclusion criteria: 1. Patients with an incomplete diagnosis of IBD. 2. Patients with a history of primary immunodeficiency disorders. 3. Patients who have received solid organ or bone marrow transplantation.

Design outcomes

Primary

Measure	Time frame
Coexisting autoimmune disorders among (IBD) patients measured using patient records at a single time point	—

Secondary

Measure	Time frame
Disease severity and disease complication measured using patient records at a single time point	—

Countries

Saudi Arabia

Contacts

Public ContactAhmed Alghamdi

aalghamedi80@gmail.com+966 112889999 EXT 21301

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026